Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered question first ministerially corrected answering member label attachment file name file name title title previous answer version answering member constituency answering member printed answering member label attachment file name title
tabling member	label

Search

454211

	registered interest
	date	23/02/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mental Health Services: Children and Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the announcement in paragraph 1.233 of Budget 2015, HC 1093, of additional funding for children and young people's mental health services, how much of this funding has been spent by NHS England to date; how such funding has been spent; and how much in total he anticipates NHS England will have spent by the end of the current financial year.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	27979
	answer	answer is ministerial correction date of answer 02/03/2016 answer text <p>In regard to the announcement in paragraph 1.233 of Budget 2015, HC1093 March Budget 2015, of the £1.25 billion additional funding for children and young people's mental health services, the following amount has been allocated to each clinical commissioning group (CCG):</p><p> </p><p>For 2015-16, £105 million has been allocated to CCGs, of which:</p><p>- £75 million has been allocated to transform local services through delivery of the Local Transformation Plans; and</p><p>- £30 million has been allocated for new community based eating disorder services in every area of the country.</p><p> </p><p><del class="ministerial">For 2016-17, £119 million has been included in CCG baseline allocations, of which</del></p><p><del class="ministerial">£30 million eating disorders funding will be allocated once the split of this funding has been agreed. The attached table contains a breakdown of the £105 million and the £119 million by CCG.</del></p><p><ins class="ministerial">For 2016-17, £119 million has been included in CCG baseline allocations. £30 million eating disorders funding will also be allocated once the split of this funding has been agreed. The attached table contains a breakdown of the £105 million and the £119 million by CCG.</ins></p><p>Year to date spend information is not available.</p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 02/03/2016 17:49:18 question first ministerially corrected 07/03/2016 18:21:38 answering member 1201 label Biography information for Alistair Burt attachment 1 file name CYP Allocations breakdown.xlsx title Revised allocations table previous answer version 48676 answering member constituency North East Bedfordshire answering member printed Alistair Burt answering member 1201 label Biography information for Alistair Burt attachment 1 file name pq27979 table.XLSX title Table
	tabling member	1439 label Biography information for Norman Lamb

454232

	registered interest
	date	23/02/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mental Health Services: Children and Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to paragraph 1.233 of the March Budget 2015, how much of the £1.25 billion investment in mental health services has been allocated to children and young people's mental health in each clinical commissioning group in (a) 2015-16 and (b) 2016-17.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	28160
	answer	answer is ministerial correction date of answer 02/03/2016 answer text <p>In regard to the announcement in paragraph 1.233 of Budget 2015, HC1093 March Budget 2015, of the £1.25 billion additional funding for children and young people's mental health services, the following amount has been allocated to each clinical commissioning group (CCG):</p><p> </p><p>For 2015-16, £105 million has been allocated to CCGs, of which:</p><p>- £75 million has been allocated to transform local services through delivery of the Local Transformation Plans; and</p><p>- £30 million has been allocated for new community based eating disorder services in every area of the country.</p><p> </p><p><del class="ministerial">For 2016-17, £119 million has been included in CCG baseline allocations, of which</del></p><p><del class="ministerial">£30 million eating disorders funding will be allocated once the split of this funding has been agreed. The attached table contains a breakdown of the £105 million and the £119 million by CCG.</del></p><p><ins class="ministerial">For 2016-17, £119 million has been included in CCG baseline allocations. £30 million eating disorders funding will also be allocated once the split of this funding has been agreed. The attached table contains a breakdown of the £105 million and the £119 million by CCG.</ins></p><p>Year to date spend information is not available.</p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 02/03/2016 17:49:18 question first ministerially corrected 07/03/2016 18:21:28 answering member 1201 label Biography information for Alistair Burt attachment 1 file name CYP Allocations breakdown.xlsx title Revised allocations table previous answer version 48680 answering member constituency North East Bedfordshire answering member printed Alistair Burt answering member 1201 label Biography information for Alistair Burt attachment 1 file name pq27979 table.XLSX title Table
	tabling member	1439 label Biography information for Norman Lamb

777814

	registered interest
	date	25/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prescription Drugs: Prices
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, which prescription drugs had the highest increase in price to the NHS in the last 10 years for which data is available.
	tabling member constituency	Vale of Clwyd
	tabling member printed	Chris Ruane
	uin	109619
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>The table below shows the top five individual medicines <del class="ministerial">and chemicals</del> that have shown the highest increase in <ins class="ministerial">cost</ins> <del class="ministerial">price </del> over the last 10 years for Net Ingredient Cost (NIC) per prescription item <del class="ministerial">and NIC per quantity</del>. Prescription medicines<del class="ministerial">/chemicals</del> have only been included where there was prescribing in both 2006 and 2016.</p><p><ins class="ministerial">For any medicine listed, it does not necessarily mean that the price has increased. For example, the cost per prescription item will be higher if the quantity being prescribed per prescription item has increased.</ins></p><p>This is based on Prescription Cost Analysis (PCA) data. PCA data is based on analysis of all prescriptions dispensed in the community i.e. by community pharmacists and appliance contractors, dispensing doctors, and prescriptions submitted by prescribing doctors for items personally administered in England. PCA data do not cover drugs dispensed in hospitals, including mental health trusts, or private prescriptions.</p><p> </p><p>Costs vary over time due to numerous factors including medicines going off patent and becoming available generically, unlicensed medicines becoming licensed medicines, shortages, the level of competition for generic medicines, as well as centrally agreed pricing schemes such as the Pharmaceutical Price Regulation Scheme.</p><p> </p><p>The Department is working closely with the Competition and Markets Authority on a number of investigations into unwarranted price rises of unbranded generic medicines. Where companies have breached competition law, we will seek damages and invest that money back into the National Health Service.</p><p> </p><table><tbody><tr><td colspan="4"><p>The top five medicines with the highest increase in Net Ingredient<sup>1</sup> Cost per prescription item<sup>2</sup></p></td></tr><tr><td><p>Drug Name</p></td><td><p>2006</p></td><td><p>2016</p></td><td><p>Increase</p></td></tr><tr><td><p>Orfadin_Cap 10mg</p></td><td><p>£5,436.74</p></td><td><p>£20,030.86</p></td><td><p>£14,594.12</p></td></tr><tr><td><p>Cerezyme_I/V Inf 400u Vl (Dry)</p></td><td><p>£18,143.17</p></td><td><p>£30,397.85</p></td><td><p>£12,254.68</p></td></tr><tr><td><p>Chenodeoxycholic Acid_Cap 250mg</p></td><td><p>£88.57</p></td><td><p>£9,580.10</p></td><td><p>£9,491.54</p></td></tr><tr><td><p>Trientine Dihydroch_Cap 300mg (Old)</p></td><td><p>£218.58</p></td><td><p>£5,488.22</p></td><td><p>£5,269.64</p></td></tr><tr><td><p>Sod Benz_Liq Spec 400mg/5ml</p></td><td><p>£361.95</p></td><td><p>£4,352.92</p></td><td><p>£3,990.96</p></td></tr></tbody></table><p>Source: Prescription Cost Analysis</p><p> </p><p>Notes:</p><p> </p><p><sup>1</sup>NIC is the basic cost of a drug. It does not take account of discounts, dispensing costs, fees or prescription charges income, so the amount the NHS spent will be slightly different.</p><p> </p><p><sup>2</sup>Prescriptions are written on a prescription form known as an FP10. Each single item written on the form is counted as a prescription item.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/11/2017 14:32:18 question first ministerially corrected 12/12/2017 13:55:12 answering member 4067 label Biography information for Steve Brine previous answer version 20077 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
	tabling member	534 label Biography information for Chris Ruane

522126

	registered interest
	date	26/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Human Papillomavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether the Medicines and Healthcare Products Regulatory Agency holds any clinical trial data for HPV vaccines which is not in the public domain.
	tabling member constituency	Denton and Reddish
	tabling member printed	Andrew Gwynne
	uin	38833
	answer	answer is ministerial correction date of answer 07/06/2016 answer text <p>There are <del class="ministerial">two</del> <ins class="ministerial">three </ins>human papilloma virus vaccines licensed in the European Union: Cervarix<ins class="ministerial">,</ins> <del class="ministerial">and</del> <ins class="ministerial">Gardasil and </ins>Gardasil 9. These products are licensed centrally throughout Europe by the European Commission via the European Medicines Agency (EMA). Applicants for centrally authorised products are required to submit all relevant supporting clinical trials data, whether published or not, to the EMA directly and not to the Medicines and Healthcare products Regulatory Agency.</p><p> </p><p>Under current medicines legislation, the EMA database registers all EU-approved clinical trials of investigational medicinal products. Since March 2011 this information has been publicly accessible through the EU Clinical Trials Register (except adult Phase 1 trials). The EU Clinical Trials Register includes all EU-conducted trials since May 2004 when the Clinical Trials Directive was implemented and can be found here:</p><p> </p><p><a href="https://www.clinicaltrialsregister.eu/ctr-search/search" target="_blank">https://www.clinicaltrialsregister.eu/ctr-search/search</a></p><p> </p><p>Furthermore since July 2014 clinical trial sponsors have been required to provide a summary of their trial results uploaded onto the EU Clinical Trials Register within one year of their trial completing. There is a two year programme of back-loading underway to provide summaries of trial results for all trials on the Register back to when the EudraCT database was initiated in May 2004.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 07/06/2016 10:57:37 question first ministerially corrected 13/06/2016 10:14:27 answering member 4020 label Biography information for George Freeman previous answer version 2228 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
	tabling member	1506 label Biography information for Andrew Gwynne

176781

	registered interest
	date	29/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether joint committees of NHS England and clinical commissioning groups are permitted to deviate from national service specifications for specialised services.
	tabling member constituency	Walsall South
	tabling member printed	Valerie Vaz
	uin	222695
	answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>NHS England is the accountable commissioner and budget holder for all specialised services as set out in The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, with the Manual for prescribed specialised services providing further detail.</p><p> </p><p> </p><p> </p><p>NHS England has achieved significant progress in developing a set of nationally consistent service standards and commissioning policies, which ensure equity of access to high quality services across the board. Those standards and policies will continue to apply for those specialised services which are to be collaboratively commissioned by NHS England and clinical commissioning groups.</p><p> </p><p> </p><p> </p><p>NHS England is currently in the process of agreeing the guidance on the collaborative commissioning arrangements which will be in place from 1 April 2015.</p><p> </p><p> </p><p> </p><p>NHS England has clarified that where there are collaboratively commissioned services, NHS England will retain the full financial risk for these services for 2015/16. NHS England has advised us that there will be further work conducted over the next year to advise on the range of specialised services for which NHS England should remain the accountable commissioner and budget holder for 2016/17 and future years.</p><p> </p><p> </p><p> </p><p>Copies of The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 and the Manual for prescribed specialised services are attached.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison attachment 1 file name nhs-england-and-ccg-regulations.pdf title Regulations NHS Commissioning Board & CCGs 2 file name pss-manual.pdf title Manual prescribed specialised services question first answered 03/02/2015 15:09:14 question first ministerially corrected 03/02/2015 15:20:37 answering member 3918 label Biography information for Jane Ellison previous answer version 42619 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	4076 label Biography information for Valerie Vaz

176784

	registered interest
	date	29/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether NHS England will remain the sole budget-holder and accountable commissioner for all specialised services.
	tabling member constituency	Walsall South
	tabling member printed	Valerie Vaz
	uin	222694
	answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>NHS England is the accountable commissioner and budget holder for all specialised services as set out in The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, with the Manual for prescribed specialised services providing further detail.</p><p> </p><p> </p><p> </p><p>NHS England has achieved significant progress in developing a set of nationally consistent service standards and commissioning policies, which ensure equity of access to high quality services across the board. Those standards and policies will continue to apply for those specialised services which are to be collaboratively commissioned by NHS England and clinical commissioning groups.</p><p> </p><p> </p><p> </p><p>NHS England is currently in the process of agreeing the guidance on the collaborative commissioning arrangements which will be in place from 1 April 2015.</p><p> </p><p> </p><p> </p><p>NHS England has clarified that where there are collaboratively commissioned services, NHS England will retain the full financial risk for these services for 2015/16. NHS England has advised us that there will be further work conducted over the next year to advise on the range of specialised services for which NHS England should remain the accountable commissioner and budget holder for 2016/17 and future years.</p><p> </p><p> </p><p> </p><p>Copies of The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 and the Manual for prescribed specialised services are attached.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison attachment 1 file name nhs-england-and-ccg-regulations.pdf title Regulations NHS Commissioning Board & CCGs 2 file name pss-manual.pdf title Manual prescribed specialised services question first answered 03/02/2015 15:09:14 question first ministerially corrected 03/02/2015 15:23:29 answering member 3918 label Biography information for Jane Ellison previous answer version 42621 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	4076 label Biography information for Valerie Vaz

607534

	registered interest
	date	21/10/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Docklands Medical Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether Docklands Medical Services Ltd were registered with the Care Quality Commission for the provision of patient transport services during July, August and September 2016; and if he will make a statement.
	tabling member constituency	Brighton, Pavilion
	tabling member printed	Caroline Lucas
	uin	49779
	answer	answer is ministerial correction date of answer 26/10/2016 answer text <p>The Care Quality Commission (CQC) is the independent regulator of health and adult social care in England. The CQC makes decisions on whether to register providers based on the requirements of the Health and Social Care Act 2008.</p><p> </p><p>The CQC provides assurance that all registered providers are meeting the relevant standards and then through a system of monitoring and ongoing inspection to make sure that standards are being maintained.</p><p> </p><p>The CQC has advised us that for the period July, August and September 2016 Coperforma held the contract with High Weald Lewes Haven Clinical Commissioning Group (CCG) to provide Patient Transport Services to the population of Brighton and elsewhere. The CQC has confirmed that Coperforma were registered to provide patient transport services during the period in question.</p><p> </p><p>The CQC has confirmed that Docklands Medical Services Ltd was not registered to provide patient transport services during the period in question. When it is brought to the attention of the CQC that a provider may have been delivering a regulated activity without registration, they investigate. If the CQC finds evidence to show that regulated activity is or has been delivered whilst unregistered then the CQC may prosecute. It is an offence under the Health and Social Care Act 2008 to carry out a regulated activity - in this case patient transport services - without being registered with the CQC. The CQC is investigating whether an offence has been committed.</p><p> </p><p>The Department understands that <ins class="ministerial">when</ins> the High Weald Lewes Havens CCG identified that the <ins class="ministerial">CQC registration in question related </ins><del class="ministerial">registered provider Coperforma had subcontracted service delivery</del> to Docklands Medical Services <ins class="ministerial">(London)</ins> <del class="ministerial">Ltd</del> <ins class="ministerial">rather than Docklands Medical Services Ltd, they contacted </ins><del class="ministerial">and immediately instructed</del> Coperforma <ins class="ministerial">asking them to confirm the relevant CQC registration status.</ins><del class="ministerial"> to cease using Docklands Medical Services Limited as a subcontractor. This was immediately actioned by Coperforma. </del></p><p><ins class="ministerial">I have also asked NHS England to investigate this provision of transport services during July, August and September 2016.</ins></p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 26/10/2016 18:02:42 question first ministerially corrected 01/11/2016 12:45:02 answering member 1542 label Biography information for Philip Dunne previous answer version 16824 answering member constituency Ludlow answering member printed Mr Philip Dunne answering member 1542 label Biography information for Philip Dunne
	tabling member	3930 label Biography information for Caroline Lucas

222966

	registered interest
	date	23/02/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mental Health Services: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when he expects that the Child and Adolescent Mental Health Services Dataset will start publishing data; and if he will make a statement.
	tabling member constituency	Liverpool, Wavertree
	tabling member printed	Luciana Berger
	uin	225018
	answer	answer is ministerial correction date of answer 26/02/2015 answer text <p><ins class="ministerial">The Health and Social Care Information Centre advise that the collection of data for the Child and Adolescent Mental Health Services dataset will start at the beginning of February 2016. The first submission period will cover January to March 2016. Statistical reports based on the initial data collection will be published in mid-2016.</ins></p><p> </p><p> </p><p> </p><p><del class="ministerial">The National Institute for Health and Care Excellence guidance <em>Multiple sclerosis: management of multiple sclerosis in primary and secondary care</em>, updated in October 2014, sets out best practice on the diagnosis, treatment, care and support of people with multiple sclerosis (MS). The guidance makes a range of recommendations on drug based treatments for MS, but also highlights the importance of involving professionals who can meet the needs of the patient in the best way, such as physiotherapists and occupational therapists. </del></p><p> </p><p> </p><p><ins class="ministerial"></ins></p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p><del class="ministerial">With regard to early diagnosis, MS is a difficult condition to diagnose as a number of the symptoms such as fatigue, depression or dizziness may be unrelated. The guidance sets out a number of initial presentations that clinicians should be aware of when looking for signs of MS. It also recommends a number of assessments a clinician should make, including testing of vision and blood tests before referral to a consultant neurologist, who can confirm or exclude a diagnosis of MS, subject to investigation.</del></p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 26/02/2015 15:20:43 question first ministerially corrected 27/02/2015 13:56:12 answering member 1439 label Biography information for Norman Lamb previous answer version 46777 answering member constituency North Norfolk answering member printed Norman Lamb answering member 1439 label Biography information for Norman Lamb
	tabling member	4036 label Biography information for Luciana Berger

176783

	registered interest
	date	29/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when NHS England will publish details of the co-commissioning of specialised services.
	tabling member constituency	Walsall South
	tabling member printed	Valerie Vaz
	uin	222693
	answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>NHS England is the accountable commissioner and budget holder for all specialised services as set out in The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, with the Manual for prescribed specialised services providing further detail.</p><p> </p><p> </p><p> </p><p>NHS England has achieved significant progress in developing a set of nationally consistent service standards and commissioning policies, which ensure equity of access to high quality services across the board. Those standards and policies will continue to apply for those specialised services which are to be collaboratively commissioned by NHS England and clinical commissioning groups.</p><p> </p><p> </p><p> </p><p>NHS England is currently in the process of agreeing the guidance on the collaborative commissioning arrangements which will be in place from 1 April 2015.</p><p> </p><p> </p><p> </p><p>NHS England has clarified that where there are collaboratively commissioned services, NHS England will retain the full financial risk for these services for 2015/16. NHS England has advised us that there will be further work conducted over the next year to advise on the range of specialised services for which NHS England should remain the accountable commissioner and budget holder for 2016/17 and future years.</p><p> </p><p> </p><p> </p><p>Copies of The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 and the Manual for prescribed specialised services are attached.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison attachment 1 file name nhs-england-and-ccg-regulations.pdf title Regulations NHS Commissioning Board & CCGs 2 file name pss-manual.pdf title Manual prescribed specialised services question first answered 03/02/2015 15:09:14 question first ministerially corrected 03/02/2015 15:21:10 answering member 3918 label Biography information for Jane Ellison previous answer version 42620 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	4076 label Biography information for Valerie Vaz

754729

	registered interest
	date	20/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pharmacy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the total number of repeat prescriptions issued by (a) high street and (b) internet pharmacies has been in each year since 2007 in (i) England and (ii) each local authority area.
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	uin	6406
	answer	answer is ministerial correction date of answer 11/09/2017 answer text <p>The total number of repeat dispensing prescription items issued by wholly distance selling pharmacies, including internet pharmacies, and other community pharmacies, including those on the high street, for each year since April 2013 in England is detailed in the table below:</p><table><tbody><tr><td><p>Time Period</p></td><td><p>Repeat Dispensing Prescription Items for Distant Selling Pharmacies</p></td><td><p>Repeat Dispensing Prescription Items for Other Community Pharmacies</p></td><td><p>Yearly Total</p></td></tr><tr><td><p>2013 (Apr-Dec 2013)</p></td><td><p>625,157</p></td><td><p>49,222,450</p></td><td><p>49,847,607</p></td></tr><tr><td><p>2014 (Jan-Dec 2014)</p></td><td><p>1,076,060</p></td><td><p>73,769,909</p></td><td><p>74,845,969</p></td></tr><tr><td><p>2015 (Jan-Dec 2015)</p></td><td><p>1,482,942</p></td><td><p>84,411,853</p></td><td><p>85,894,795</p></td></tr><tr><td><p>2016 (Jan-Dec 2016)</p></td><td><p>2,001,326</p></td><td><p>95,730,820</p></td><td><p>97,732,146</p></td></tr><tr><td><p>2017 (Jan-May 2017)</p></td><td><p>930,753</p></td><td><p>42,216,958</p></td><td><p>43,147,711</p></td></tr><tr><td><p>Total</p></td><td><p>6,116,238</p></td><td><p>345,351,990</p></td><td><p>351,468,228</p></td></tr></tbody></table><p>The requested data is not provided before 2013 as the NHS Business Services Authority only holds prescription payment data for a period of 60 months, at which point it is destroyed in line with their records management policy. Also this coincides with NHS England becoming responsible for commissioning community pharmacy services from April 2013. As such, data is attached on repeat dispensing prescription items by NHS England local areas, rather than local authority areas.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/09/2017 14:29:46 question first ministerially corrected 12/09/2017 09:25:45 answering member 4067 label Biography information for Steve Brine attachment 1 file name PQ6406 Repeats appendix FINAL.xlsx title Repeat prescriptions by NHS England area previous answer version 9595 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
	tabling member	4244 label Biography information for Jonathan Ashworth